Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds.
The effects of flavonoids, antioxidants and related compounds on 12-O-tetradecanoylphorbol-13-acetate (TPA)-caused epidermal ornithine decarboxylase (ODC) induction, DNA synthesis and skin tumor promotion, and on epidermal lipoxygenase activity, were investigated using CD-1 mice. Morin, fisetin , kaempferol and n-propyl gallate potently inhibited epidermal lipoxygenase activity, and esculetin , butylated hydroxyanisole (BHA), alpha-naphthol and 2,3- dihydroxynaphthalene (2,3- DHNA ) moderately inhibited it. alpha-Tocopherol, (+)catechin, (-) epicatechin and butylated hydroxytoluene (BHT) were inactive. Similarly, morin, fisetin , kaempferol and n-propyl gallate markedly inhibited TPA-caused ODC induction. Esculetin , BHA, alpha-naphthol, 2,3- DHNA and alpha-tocopherol inhibited it less potently, but significantly. (+)Catechin, (-) epicatechin and BHT failed to inhibit or only slightly inhibited TPA-caused ODC induction. TPA-caused DNA synthesis was not inhibited by morin, esculetin , (+)-catechin or alpha-tocopherol. The TPA-induced skin tumor promotion was markedly inhibited by morin and slightly suppressed by esculetin and alpha-tocopherol, but (+)-catechin was inactive. Thus, the inhibitory effects of flavonoids and antioxidants on the TPA-caused ODC induction and tumor promotion were roughly parallel with their activities of lipoxygenase inhibition. These results further support our hypothesis that a lipoxygenase product(s) is involved in the mechanism of TPA-caused ODC induction and tumor promotion.
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D004790:Enzyme Induction / Q000187:drug effects; D004817:Epidermis / Q000187:drug effects* / Q000201:enzymology; D005260:Female; D005419:Flavonoids / Q000494:pharmacology*; D016859:Lipoxygenase Inhibitors; D051379:Mice; D008815:Mice, Inbred Strains; D009955:Ornithine Decarboxylase / Q000096:biosynthesis*; D065108:Ornithine Decarboxylase Inhibitors; D010704:Phorbols / Q000494:pharmacology*; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000201:enzymology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D013997:Time Factors
D000975:Antioxidants; D005419:Flavonoids; D016859:Lipoxygenase Inhibitors; D065108:Ornithine Decarboxylase Inhibitors; D010704:Phorbols; D009955:Ornithine Decarboxylase; D013755:Tetradecanoylphorbol Acetate